StockNews.com began coverage on shares of 22nd Century Group (NASDAQ:XXII – Free Report) in a report published on Wednesday morning. The brokerage issued a sell rating on the biotechnology company’s stock.
22nd Century Group Stock Performance
Shares of XXII opened at $0.09 on Wednesday. The firm has a market capitalization of $4.27 million, a P/E ratio of 0.00 and a beta of 1.45. The company has a debt-to-equity ratio of 1.59, a current ratio of 1.09 and a quick ratio of 0.67. 22nd Century Group has a one year low of $0.09 and a one year high of $5.69. The business has a fifty day moving average of $0.18 and a 200 day moving average of $0.61.
22nd Century Group (NASDAQ:XXII – Get Free Report) last released its quarterly earnings results on Tuesday, November 12th. The biotechnology company reported ($0.54) earnings per share (EPS) for the quarter. 22nd Century Group had a negative net margin of 144.09% and a negative return on equity of 380.39%. The firm had revenue of $5.95 million for the quarter.
Hedge Funds Weigh In On 22nd Century Group
About 22nd Century Group
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
Featured Stories
- Five stocks we like better than 22nd Century Group
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- What is Put Option Volume?
- Time to Load Up on Home Builders?
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.